gabexate has been researched along with Chronic Kidney Diseases in 2 studies
Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ueda, M | 2 |
| Uchimura, K | 2 |
| Narita, Y | 2 |
| Miyasato, Y | 2 |
| Mizumoto, T | 2 |
| Morinaga, J | 2 |
| Hayata, M | 2 |
| Kakizoe, Y | 2 |
| Adachi, M | 2 |
| Miyoshi, T | 2 |
| Shiraishi, N | 1 |
| Kadowaki, D | 2 |
| Sakai, Y | 2 |
| Mukoyama, M | 2 |
| Kitamura, K | 2 |
| Nakagawa, T | 1 |
| Hirata, S | 1 |
2 other studies available for gabexate and Chronic Kidney Diseases
| Article | Year |
|---|---|
The serine protease inhibitor camostat mesilate attenuates the progression of chronic kidney disease through its antioxidant effects.
Topics: Animals; Antihypertensive Agents; Antioxidants; Blood Pressure; Creatinine; Disease Progression; Est | 2015 |
Combination therapy with renin-angiotensin-aldosterone system inhibitor telmisartan and serine protease inhibitor camostat mesilate provides further renoprotection in a rat chronic kidney disease model.
Topics: Aldosterone; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Benzimidazol | 2016 |